Camden Capital, LLC Zoetis Inc. Transaction History
Camden Capital, LLC
- $916 Million
- Q1 2025
A detailed history of Camden Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 6,191 shares of ZTS stock, worth $976,754. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,191
Previous 1,386
346.68%
Holding current value
$976,754
Previous $225,000
352.89%
% of portfolio
0.11%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding ZTS
# of Institutions
2,112Shares Held
421MCall Options Held
1.98MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA41.6MShares$6.56 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.81 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.12 Billion0.14% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.51 Billion2.42% of portfolio
-
Morgan Stanley New York, NY12.7MShares$2.01 Billion0.15% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $73.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...